Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors
Open Access
- 1 August 2004
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 17 (2), 22-30
- https://doi.org/10.3171/foc.2004.17.2.4
Abstract
The optimal management of glomus jugulare tumors remains controversial. Available treatments were once associated with poor outcomes and significant complication rates. Advances in skull base surgery and the delivery of radiation therapy by stereotactic radiosurgery have improved the results obtained using these treatment options. The authors summarize and compare the contemporary outcomes and complications for these therapies. Papers published between 1994 and 2004 that detailed the use of radiosurgery or surgery to treat glomus jugulare tumors were reviewed. Eight radiosurgery series including 142 patients and seven surgical studies including 374 patients were evaluated for neurological outcome, change in tumor size (radiosurgery) or percent of total resection (surgery), recurrences, tumor control, need for further treatment, and complications. The mean age at treatment for patients who underwent surgery and radiosurgery was 47.3 and 56.7 years, respectively. The mean follow-up duration was 49.2 and 39.4 months, respectively. The surgical control rate was 92.1%, with 88.2% of tumors totally resected in the initial surgery. A cerebrospinal fluid leak occurred in 8.3% of patients who underwent surgery and recurrences were found in 3.1%; the mortality rate was 1.3%. Among patients who underwent radiosurgery, tumors diminished in 36.5%, whereas 61.3% had no change in tumor size, and subjective or objective improvements occurred in 39%. Despite the presence of residual tumor in 100% of radiosurgically treated patients, recurrences were found in only 2.1%, the morbidity rate was 8.5%, and there were no deaths. Death and recurrences after these treatments are infrequent, and therefore both treatments are considered to be safe and efficacious. Although surgery is associated with higher morbidity rates, it immediately and totally eliminates the tumor. The radiosurgery results are very promising, although the incidence of late recurrence (after 10–20 years) is unknown. The optimal management of glomus jugulare tumors remains controversial. Available treatments were once associated with poor outcomes and significant complication rates. Advances in skull base surgery and the delivery of radiation therapy by stereotactic radiosurgery have improved the results obtained using these treatment options. The authors summarize and compare the contemporary outcomes and complications for these therapies. Papers published between 1994 and 2004 that detailed the use of radiosurgery or surgery to treat glomus jugulare tumors were reviewed. Eight radiosurgery series including 142 patients and seven surgical studies including 374 patients were evaluated for neurological outcome, change in tumor size (radiosurgery) or percent of total resection (surgery), recurrences, tumor control, need for further treatment, and complications. The mean age at treatment for patients who underwent surgery and radiosurgery was 47.3 and 56.7 years, respectively. The mean follow-up duration was 49.2 and 39.4 months, respectively. The surgical control rate was 92.1%, with 88.2% of tumors totally resected in the initial surgery. A cerebrospinal fluid leak occurred in 8.3% of patients who underwent surgery and recurrences were found in 3.1%; the mortality rate was 1.3%. Among patients who underwent radiosurgery, tumors diminished in 36.5%, whereas 61.3% had no change in tumor size, and subjective or objective improvements occurred in 39%. Despite the presence of residual tumor in 100% of radiosurgically treated patients, recurrences were found in only 2.1%, the morbidity rate was 8.5%, and there were no deaths. Death and recurrences after these treatments are infrequent, and therefore both treatments are considered to be safe and efficacious. Although surgery is associated with higher morbidity rates, it immediately and totally eliminates the tumor. The radiosurgery results are very promising, although the incidence of late recurrence (after 10–20 years) is unknown.Keywords
This publication has 54 references indexed in Scilit:
- Stereotactic linear accelerater‐based radiosurgery for the treatment of patients with glomus jugulare tumorsCancer, 2003
- Complex tumors of the glomus jugulare: criteria, treatment, and outcomeJournal of Neurosurgery, 2002
- Efficiency of Gamma Knife Radiosurgery in the Treatmentof Glomus Jugulare Tumorsmin - Minimally Invasive Neurosurgery, 2001
- Glomus Jugulare Tumor Metastatic to the Sacrum after High-dose Radiation TherapyNeurosurgery, 1995
- Radiosurgery with the first Austrian cobalt-60 Gamma-unitActa Neurochirurgica, 1994
- Long-term effects of radiation therapy for a catecholamine-producing glomus jugulare tumorJournal of Neurosurgery, 1994
- Conservation surgery for glomus jugulare tumors: The value of early diagnosisThe Laryngoscope, 1990
- Radiation or surgery for chemodectoma of the temporal bone: A review of local control and complicationsHead & Neck, 1990
- A combined infratemporal and posterior fossa approach for the removal of giant glomus tumors and chondrosarcomasSurgical Neurology, 1987
- Complications in the management of large glomus jugulae tumorsThe Laryngoscope, 1987